Lycorine is primarily investigated for its antiviral and anticancer properties. It has shown inhibitory effects against a range of viruses, including coronaviruses, by interfering with viral protein synthesis and replication processes. In cancer research, lycorine induces apoptosis and inhibits cell proliferation in various tumor cell lines, making it a candidate for development as a chemotherapeutic agent. It also exhibits anti-inflammatory and acetylcholinesterase inhibitory activities, suggesting potential use in neurodegenerative disorders like Alzheimer’s disease. Due to its diverse biological activities, lycorine is of interest in pharmaceutical research, though its clinical application is still under investigation.